Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591694 · ClinicalTrials.gov registry record
National Child Traumatic Stress Network (NCTSN) Quality Improvement Initiative Database
A clinical trial of Depression and Anxiety, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Completed
- Registry status
- 4,193
- Enrollment target
- 1
- Study location
NCT01591694: Completed study of Depression and Anxiety, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT01591694 is a study of Depression and Anxiety that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 4,193 participants, above the 780-participant average among 679 other Depression trials with a reported enrollment target (438% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01591694, a study of Depression and Anxiety, has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- COMPLETED
- Registry status
- 4,193 participants
- Enrollment target
- 1
- Study location
Study Summary
Trauma-informed treatment will improve emotional regulation and behavior.
Primary Outcome
Improved behavioral and emotional regulation, i.e., improved behavior compliance, improved misbehavior symptoms, reduced symptoms of anxiety, depression, attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder, and post traumatic stress syndrome (PTSD). Improved sleep, toileting, parent-child attachment, and mood regulation.
Conditions Studied
Study Locations (1)
Maryland
- Family Center at Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,193 participants |
| Start Date | 2012-04 |
| Est. Completion | 2017-02-07 |
What the finished NCT01591694 record still lists
NCT01591694 is an observational study that tracks outcomes without assigning an intervention. Its 4,193 participants enrollment target places it among the larger protocols in the corpus, above the 780-participant average among 679 other Depression trials with a reported enrollment target (438% higher).
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT01591694 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01591694 about?
NCT01591694 is a clinical study titled "National Child Traumatic Stress Network (NCTSN) Quality Improvement Initiative Database". Trauma-informed treatment will improve emotional regulation and behavior.
What is the current status of trial NCT01591694?
This trial is currently completed. The enrollment target is 4,193 participants. The study started on 2012-04. Estimated completion is 2017-02-07.
What conditions does trial NCT01591694 study?
This clinical trial studies the following conditions: Depression, Anxiety, Post Traumatic Stress Disorder, ADHD, Conduct Disorder.
Who is sponsoring clinical trial NCT01591694?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01591694 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01591694's enrollment target sits among peer trials
4,193 16th of 679 higher than 664 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- NCT07209098 · 4,200 participants
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia